Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.588
https://www.valueinhealthjournal.com/article/S1098-3015(13)00659-1/fulltext
Section Title :
Systemic Disorders/Conditions
Section Order :
135
First Page :
A122
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00659-1&doi=10.1016/j.jval.2013.03.588